NO20080950L - Topiske formuleringer inneholdende O-desmetylvenlafaksin (ODV) eller salter derav - Google Patents

Topiske formuleringer inneholdende O-desmetylvenlafaksin (ODV) eller salter derav

Info

Publication number
NO20080950L
NO20080950L NO20080950A NO20080950A NO20080950L NO 20080950 L NO20080950 L NO 20080950L NO 20080950 A NO20080950 A NO 20080950A NO 20080950 A NO20080950 A NO 20080950A NO 20080950 L NO20080950 L NO 20080950L
Authority
NO
Norway
Prior art keywords
odv
desmethylvenlafaxine
topical formulations
salts
formulations containing
Prior art date
Application number
NO20080950A
Other languages
English (en)
Norwegian (no)
Inventor
Syed Muzafar Shah
Rao Tatapudy
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37517243&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20080950(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20080950L publication Critical patent/NO20080950L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20080950A 2005-09-07 2008-02-26 Topiske formuleringer inneholdende O-desmetylvenlafaksin (ODV) eller salter derav NO20080950L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71540005P 2005-09-07 2005-09-07
PCT/US2006/034712 WO2007030537A1 (en) 2005-09-07 2006-09-06 Topical formulations containing o-desmethyl venlafaxine (odv) or its salts

Publications (1)

Publication Number Publication Date
NO20080950L true NO20080950L (no) 2008-05-26

Family

ID=37517243

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080950A NO20080950L (no) 2005-09-07 2008-02-26 Topiske formuleringer inneholdende O-desmetylvenlafaksin (ODV) eller salter derav

Country Status (18)

Country Link
US (1) US20070054964A1 (zh)
EP (1) EP1924251A1 (zh)
JP (1) JP2009507078A (zh)
KR (1) KR20080041695A (zh)
CN (1) CN101300002A (zh)
AR (1) AR055629A1 (zh)
AU (1) AU2006287580A1 (zh)
BR (1) BRPI0615769A2 (zh)
CA (1) CA2620164A1 (zh)
CR (1) CR9751A (zh)
EC (1) ECSP088251A (zh)
GT (1) GT200600397A (zh)
IL (1) IL189598A0 (zh)
NO (1) NO20080950L (zh)
PE (1) PE20070430A1 (zh)
RU (1) RU2008106932A (zh)
TW (1) TW200744566A (zh)
WO (1) WO2007030537A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2692738A1 (en) * 2007-07-12 2009-01-15 Dr. Reddy's Laboratories, Ltd. O-desmethylvenlafaxine
WO2009049354A1 (en) * 2007-10-16 2009-04-23 Alphapharm Pty Ltd Controlled-release pharmaceutical formulation
WO2009069140A1 (en) * 2007-11-28 2009-06-04 Dabur Pharma Limited An improved process for preparation of letrozole and its intermediates
EP2085377A1 (en) 2008-01-29 2009-08-05 LEK Pharmaceuticals D.D. Novel salts of O-desmethyl-venlafaxine
WO2009155488A2 (en) * 2008-06-19 2009-12-23 Segrub, Llc Novel oxalate salt and crystal of o-desmethylvenlafaxine
WO2010028130A2 (en) * 2008-09-03 2010-03-11 Concert Pharmaceuticals, Inc. Antidepressant compounds
DK2621891T3 (da) * 2010-10-01 2020-02-17 Shan Dong Luye Pharm Co Ltd Polymorfer af 4-[2-dimethylamino-1-(1 hydroxycyclohexyl)ethyl]phenyl 4-methylbenzoathydrochlorid, fremgangsmåder til fremstilling og anvendelse deraf
WO2013063794A1 (en) * 2011-11-04 2013-05-10 Oil Crops Research Institute, Chinese Academy Of Agricultural Sciences A growth regulatory factor gene grf2 derived from brassica napus and the use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US4761501A (en) * 1983-10-26 1988-08-02 American Home Products Corporation Substituted phenylacetamides
US4861764A (en) * 1986-11-17 1989-08-29 Macro Chem. Corp. Percutaneous absorption enhancers, compositions containing same and method of use
US6342533B1 (en) * 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
CA2368083A1 (en) * 1999-04-06 2000-10-12 Sepracor Inc. Derivatives of venlafaxine and methods of preparing and using the same
US20020192302A1 (en) * 1999-12-16 2002-12-19 Tsung-Min Hsu Transdermal and topical administration of antidepressant drugs using basic enhancers
DE10042412B4 (de) * 2000-08-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung
DK1360169T3 (da) * 2001-02-12 2007-11-26 Wyeth Corp Succinatsalt af O-desmethyl-venlafaxin
MXPA04012347A (es) * 2002-06-10 2005-02-25 Wyeth Corp Nueva sal formiato de o-desmetilvenlafaxina.
US7345096B2 (en) * 2002-10-15 2008-03-18 Wyeth Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
MXPA06002159A (es) * 2003-08-26 2006-05-22 Becton Dickinson Co Metodos para la administracion intradermica de agentes terapeuticos.
EP1691811B1 (en) * 2003-12-11 2014-07-23 Sunovion Pharmaceuticals Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
US20060013866A1 (en) * 2004-07-16 2006-01-19 Carter Stephen G Transdermal drug delivery formulations with optimal amounts of vasodilators therein

Also Published As

Publication number Publication date
US20070054964A1 (en) 2007-03-08
KR20080041695A (ko) 2008-05-13
RU2008106932A (ru) 2009-10-20
EP1924251A1 (en) 2008-05-28
ECSP088251A (es) 2008-04-28
AR055629A1 (es) 2007-08-29
CA2620164A1 (en) 2007-03-15
PE20070430A1 (es) 2007-05-18
TW200744566A (en) 2007-12-16
WO2007030537A1 (en) 2007-03-15
JP2009507078A (ja) 2009-02-19
IL189598A0 (en) 2008-08-07
CR9751A (es) 2008-05-22
GT200600397A (es) 2007-08-28
AU2006287580A1 (en) 2007-03-15
CN101300002A (zh) 2008-11-05
BRPI0615769A2 (pt) 2011-05-24

Similar Documents

Publication Publication Date Title
NO20080950L (no) Topiske formuleringer inneholdende O-desmetylvenlafaksin (ODV) eller salter derav
NO20073628L (no) Pyridoner som er nyttige som inhibitorer av kinaser
NO20080936L (no) Transdermale medikamentleveringsinnretninger inneholdende O-desmetylvenlafaksin (ODV) eller salter derav
AR058679A1 (es) Preparacion farmaceutica que contiene meloxicam
NO20082530L (no) Imidazopyraziner som proteinkinaseinhibitorer
BRPI0509369A (pt) azaindóis úteis como inibidores de jak e outras proteìna cinases
TW200507830A (en) Bronchodilating β -agonist compositions and methods
WO2007093450A3 (en) Deuterated catecholamine derivatives and medicaments comprising said compounds
NO20071915L (no) Diaminotriazolforbindelser nyttige som proteinkinaseinhibitorer
NO20064584L (no) Tetrahydropyridoindolderivater
WO2007061661A3 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2002083079A3 (en) Aerosol compositions containing formoterol for delivery to the lungs via nebulization
NO20064347L (no) Substituerte 1,2,3,4-tetrahydroisokinolinderivater
UY28931A1 (es) Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis
EA200970791A1 (ru) N-АДАМАНТИЛБЕНЗАМИДЫ В КАЧЕСТВЕ ИНГИБИТОРОВ 11-β-ГИДРОКСИСТЕРОИДДЕГИДРОГЕНАЗЫ
NO20076508L (no) Acyloksykarbamat prodroger av traneksaminsyre og fremgangsmater for fremstilling og anvendelse derav
NO20082124L (no) Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom
BRPI0513379A (pt) derivados de sulfonamida
WO2007143607A3 (en) Method of treating atrophic vaginitis
BRPI0415683A (pt) inibidores da reabsorção de norepinefrina para o tratamento de distúrbios do sistema nervoso central
NO20075111L (no) Farmasoytisk sammensetning
UY27872A1 (es) Inhibidores de caspasa y usos de los mismos.
SG152257A1 (en) Topical preparation containing ambroxol
CY1118976T1 (el) Κρυσταλλικες τροποποιησεις της (1r,2r)-3-(3-διμεθυλαμινο-1-αιθυλ-2-μεθυλ-προπυλ)-φαινολης
NO20070502L (no) Azaindoler nyttige som inhibitorer av proteinkinaser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application